ROUNDUP GUIDE · HEALTH
Is Roundup Dangerous to Humans?
Last updated: June 9, 2026
This is one of the most-searched questions about Roundup, and the honest answer is that experts disagree. Glyphosate, the active ingredient in Roundup, has been classified as "probably carcinogenic to humans" by one major health body and as unlikely to pose a cancer risk by others. This page lays out what the research has found, where the disagreement lies, and why those questions matter both medically and legally.
For background on the chemical itself, start with What Is Glyphosate?
This page provides general educational information only and does not constitute medical or legal advice. Discuss any health concerns with a qualified medical professional.
- Scientific and regulatory bodies disagree about glyphosate's cancer risk.
- IARC classified it as "probably carcinogenic"; the EPA has reached a different conclusion.
- The most-studied possible association is with non-Hodgkin lymphoma.
- Any individual risk can depend on exposure level, duration, and personal health.
Where the Disagreement Comes From
In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). The U.S. Environmental Protection Agency, reviewing its own body of evidence, has concluded that glyphosate is not likely to be carcinogenic to humans at the doses relevant to typical use. Other regulators around the world have landed in different places. This is not a case of one side ignoring the science; it reflects genuine differences in how agencies weigh study types, exposure levels, and methods.
What "Probably Carcinogenic" Actually Means
The IARC Group 2A label describes the strength of the evidence that something can cause cancer, not how much it raises any individual's risk or at what dose. The same category includes a range of everyday exposures. So the classification is meaningful, but it is not a statement that any particular use of Roundup will cause cancer.
The Condition Most Often Discussed
The health outcome most frequently raised in glyphosate research and litigation is non-Hodgkin lymphoma, a cancer of the lymphatic system. For a focused overview of that link and how it figures into cases, see Roundup and Non-Hodgkin Lymphoma.
Why Dose and Duration Matter
As with most chemical exposure questions, risk generally depends on how much someone was exposed to and for how long. Much of the litigation involves people with heavy, repeated, long-term exposure — agricultural workers, landscapers, and groundskeepers — rather than occasional home users. That distinction often matters in how cases are evaluated.
"Associated With" Is Not "Caused By"
An association at the population level means a condition appears more often among more-exposed groups; it does not establish that glyphosate caused any one person's illness. In litigation, whether exposure can be tied to a specific diagnosis is a fact-intensive question turning on exposure history, timing, and medical evidence.
What People Often Read Next
For reported effects people search for, see Glyphosate Exposure Symptoms. For the legal landscape, see Roundup Cancer Lawsuits and the regulatory analysis in Glyphosate Lawsuits: EPA, Bayer and the Supreme Court.
Diagnosed with non-Hodgkin lymphoma after long-term Roundup or glyphosate exposure? You may qualify for a free, no-obligation case review on Lawsuit Center.
Check My Eligibility